Jacob Kimmel
jacobkimmel.bsky.social
Jacob Kimmel
@jacobkimmel.bsky.social
co-founder & president @newlimitbio.bsky.social | Prev PI @calico, PhD @ucsf | interested in aging, machine learning, genomics, & the technology production function

https://jck.bio
close to heaven, could only be better with tartine bread
April 10, 2025 at 11:01 PM
Noam is a hero. It’s a shame there are no good books about him. “Man who fed the world” doesn’t do him justice.
March 27, 2025 at 4:33 PM
thanks for sharing, reached out :)
January 14, 2025 at 5:08 AM
this is gorgeous! any trick to spotting these events?
January 3, 2025 at 9:00 PM
would love to meet while you’re in town

for hotels, South SF is probably a good 80/20. mostly oriented toward biotech travelers & ~15’ from downtown.
December 23, 2024 at 8:47 PM
the Sound Life Cohort from Allen Immunology has 100+ patients for PBMCs.

Unfortunately I don’t think there are any multi-tissue unified efforts at that scale yet, so the best data available today might need to integrate across studies.
December 9, 2024 at 3:53 AM
zenodo wrapped: which supplemental methods did you most rely upon 🙂
December 5, 2024 at 11:22 PM
excited to dig into this, congratulations to the team 🎉
November 29, 2024 at 5:50 PM
we remodeled also @newlimitbio.bsky.social hq.

we stole design ideas from bell labs & skunk works, then added glass everywhere to mimic the future we're trying to build.

we're all excited for the discoveries to come in our new space.
November 23, 2024 at 6:16 PM
we've previously discovered TF sets that reverse T cell age using a phenotypic approach. for each TF set, we ask if it makes old T cells "look" younger based on gene expression.

last month, we developed our 1st functional screening system that directly measures the impact of 100s of TF sets at once
November 23, 2024 at 6:16 PM
discovering TF sets that reverse cell age is only the first step to making a medicine. next, we'll need to formulate these TF sets into drugs.

@newlimitbio.bsky.social is leveraging LNP-mRNA technology to achieve this, similar to the COVID vaccines.
November 23, 2024 at 6:16 PM
our Metabolism team developed 2 gold-standard pre-clinical models for hepatocytes.

consistent with our previous results, old hepatocytes are more susceptible to damage than young in both settings.
November 23, 2024 at 6:16 PM
We've ported our Engine technology to human hepatocytes and received our first in vivo screening results

to our knowledge, these are the first in vivo screening data for human hepatocytes & the first 70 reprogramming sets tested to date. already we're seeing promising signals.
November 23, 2024 at 6:16 PM
jacob let’s be honest we all know you mostly use fruits
November 13, 2024 at 6:04 AM